Background: Cross-clamping of the descending aorta during operative repairs causes sudden, significant reductions in renal function that may persist well beyond arterial clamp release. Commonly used agents, such as dopamine and mannitol, have not consistently affected renal outcome in these high-risk patients. Fenoldopam mesylate is a novel, highly selective dopamine type-I agonist that preferentially dilates the renal and splanchnic vasculature, but has not been investigated in patients undergoing prolonged aortic clamping for whom adverse renal outcomes should be more likely.
Methods and Results: Twenty-two adult patients without significant pre-existing renal dysfunction and presenting for elective repairs of abdominal aortic aneurysms were studied. Fenoldopain mesylate was infused after obtaining baseline values ranging from 0.1 to 1.0 pg/kg/min for the first 24 hours postoperatively to maintain mean arterial pressure ±25% baseline. Serial renal function indices, including creatinine clearance and electrolyte fractional excretions, were measured at baseline, at aortic clamping and unclamping, and post-clamp release, and were estimated through hospital discharge. Creatinine clearance fell during abdominal exploration and clamping, reaching a nadir with clamp removal. Partial recovery occurred by 2 hours after clamp removal, and returned to baseline values by postoperative day 1 and thereafter. Fractional excretions rose rapidly throughout the operative phase. Total fenoldopam dose was directly related to the baseline creatinine clearance; after clamp removal, creatinine clearance was directly related to the mean arterial pressure at the lowest dose of fenoldopam, and inversely related to the mean arterial pressure at clamp release.
Conclusions: In elderly patients with severe vascular disease undergoing aneurysmal repairs, the use of a fenoldopam infusion in this open-label, uncontrolled trial was associated with a relatively rapid return of renal function to baseline values, despite profound decreases during aortic cross-clamping. Further studies will be necessary to investigate how fenoldopam infusions compare with traditional therapies.
1. Pass LJ, Eberhart RC, Brown JC, et al. The effect of mannitol and dopamine on the renal response to thoracic aortic cross-clamping. J Thorac Cardiovasc Surg95:608-612, 1988
2.
2. Paul MD, Mazer CD, Byrick RJ, et al. Influence of mannitol and dopamine on renal function during elective infrarenal aortic clamping in man. Am J Nephrol6:427-434, 1986
3.
3. Schwartz LB, Bissell MG, Murphy M, et al. Renal effects of dopamine in vascular surgical patients. J Vasc Surg8:367-374, 1988
4.
4. Garwood S, Hines R. Perioperative renal preservation: Dopexamine, and fenoldopam, new agents to augment renal performance. Sem Anesth Periop Med Pain17:308-318, 1998
5.
5. Hill AJ, Reneck RO, Walesby RK. A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery. J Cardiothorac Vasc Anesth7:279-284, 1993
6.
6. Shusterman NH, Elliot WJ, White WB. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med95:161-168, 1993
7.
7. Murphy MB, McCoy CE, Weber RR, et al. Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine, agonist fenoldopam. Circulation6:1312-1318, 1987
8.
8. White WB, Radford MJ, Gonzalez FM, et al. Selective dopamine-1 agonist therapy in severe hypertension: Effects of intravenous fenoldopam. J Am Coll Cardiol11:1118-1123, 1988
9.
9. Kellen M, Aronson S, Roizen M, et al. Predictive and diagnostic tests of renal failure: A review. Anesth Analg78:134-142, 1994
10.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron16:31-41, 1976
11.
11. Gilbert TB, Barnas GM, Sequeira AJ. Impact of pleurotomy, continuous positive airway pressure, and fluid balance during cardiopulmonary bypass on lung mechanics and oxygenation. J Cardiothorac Vasc Anesth10:844-849, 1996
12.
12. Gamulin Z, Forster A, Morel D, et al. Effects of infrarenal aortic cross-clamping on renal hemodynamics in humans. Anesthesiology61:394-399, 1984
13.
13. Novis BK, Roizen MF, Aronson S, et al. Association of preoperative risk factors with postoperative acute renal failure. Anesth Analg78:143-149, 1994
